OBJECTIVE: We sought to examine the associations of maternal C-reactive protein (CRP) levels with fetal growth and the risks of neonatal complications. STUDY DESIGN: CRP levels were measured in early pregnancy in 6016 women. Main outcome measures were fetal growth in each trimester and neonatal complications. RESULTS: As compared to the reference group (CRP levels<5 mg/L), elevated maternal CRP levels (≥25 mg/L) were associated with lower estimated fetal weight in third trimester and lower weight at birth (differences: -29 g, 95% confidence interval [CI], -58 to 0 and -128 g, 95% CI, -195 to -60, respectively). Elevated maternal CRP levels were also associated with an increased risk of a small size for gestational age in the offspring (adjusted odds ratio, 2.94; 95% CI, 1.61-5.36). CONCLUSION: Maternal CRP levels in early pregnancy are associated with fetal growth restriction and increased risks of neonatal complications.
OBJECTIVE: We sought to examine the associations of maternal C-reactive protein (CRP) levels with fetal growth and the risks of neonatal complications. STUDY DESIGN:CRP levels were measured in early pregnancy in 6016 women. Main outcome measures were fetal growth in each trimester and neonatal complications. RESULTS: As compared to the reference group (CRP levels<5 mg/L), elevated maternal CRP levels (≥25 mg/L) were associated with lower estimated fetal weight in third trimester and lower weight at birth (differences: -29 g, 95% confidence interval [CI], -58 to 0 and -128 g, 95% CI, -195 to -60, respectively). Elevated maternal CRP levels were also associated with an increased risk of a small size for gestational age in the offspring (adjusted odds ratio, 2.94; 95% CI, 1.61-5.36). CONCLUSION: Maternal CRP levels in early pregnancy are associated with fetal growth restriction and increased risks of neonatal complications.
Authors: Claudia J Kruithof; Marjolein N Kooijman; Cornelia M van Duijn; Oscar H Franco; Johan C de Jongste; Caroline C W Klaver; Johan P Mackenbach; Henriëtte A Moll; Hein Raat; Edmond H H M Rings; Fernando Rivadeneira; Eric A P Steegers; Henning Tiemeier; Andre G Uitterlinden; Frank C Verhulst; Eppo B Wolvius; Albert Hofman; Vincent W V Jaddoe Journal: Eur J Epidemiol Date: 2014-12-21 Impact factor: 8.082
Authors: Sarah Canetta; Andre Sourander; Heljä-Marja Surcel; Susanna Hinkka-Yli-Salomäki; Jaana Leiviskä; Christoph Kellendonk; Ian W McKeague; Alan S Brown Journal: Am J Psychiatry Date: 2014-09 Impact factor: 18.112
Authors: G S Stødle; G B Silva; L H Tangerås; L M Gierman; I Nervik; U E Dahlberg; C Sun; M H Aune; L C V Thomsen; L Bjørge; A-C Iversen Journal: Clin Exp Immunol Date: 2018-04-23 Impact factor: 4.330
Authors: Kelly K Ferguson; Elizabeth M Kamai; David E Cantonwine; Bhramar Mukherjee; John D Meeker; Thomas F McElrath Journal: Am J Reprod Immunol Date: 2018-07-08 Impact factor: 3.886
Authors: Natasja Koks; Akhgar Ghassabian; Kirstin Greaves-Lord; Albert Hofman; Vincent W V Jaddoe; Frank C Verhulst; Henning Tiemeier Journal: Paediatr Perinat Epidemiol Date: 2015-12-03 Impact factor: 3.980
Authors: Arthur J Vaught; Evan M Braunstein; Jagar Jasem; Xuan Yuan; Igor Makhlin; Solange Eloundou; Andrea C Baines; Samuel A Merrill; Shruti Chaturvedi; Karin Blakemore; C John Sperati; Robert A Brodsky Journal: JCI Insight Date: 2018-03-22
Authors: Sarbattama Sen; Sheryl L Rifas-Shiman; Nitin Shivappa; Michael D Wirth; James R Hébert; Diane R Gold; Matthew W Gillman; Emily Oken Journal: J Nutr Date: 2016-03-02 Impact factor: 4.798